Dr. Cooperberg on Ongoing Trials in Early Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Matthew R. Cooperberg, MD, MPH, an associate professor of urology, epidemiology, and biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (USCF), discusses ongoing trials in early prostate cancer.
There are several ongoing trials looking at adjuvant versus early salvage radiation therapy. Three trials that have already been published support the use of secondary radiation therapy after surgery for men with adverse pathology.
However, these trials do not determine if secondary radiation needs to be given in the adjuvant or early salvage setting, says Cooperberg.
There are also ongoing trials looking at cytoreduction for metastatic disease, explains Cooperberg.